Latest Global Markets News

The WCM Quality Global Growth Fund – Active ETF (WCMQ) is set to pay a substantial FY2025 distribution, triggering an expected 15% price adjustment as it trades ex-distribution from July 1. Investors are urged to consider the Distribution Reinvestment Plan to stay fully invested.

DroneShield has landed a $9.7 million contract package in Latin America, reinforcing its foothold in the region’s defence market with deliveries scheduled for late 2025.

NeuroScientific Biopharmaceuticals has completed its acquisition of StemSmart stem cell technology, setting the stage for a focused clinical push in treating fistulising Crohn’s disease. The company also refreshed its board and raised $7.5 million to support this next phase.

Champion Iron Limited has upsized its senior notes offering to US$500 million, pricing the debt at 7.875% interest to refinance existing credit facilities and support ongoing project development.

Alkane Resources has moved forward with its planned merger with Mandalay Resources, scheduling shareholder meetings for late July to approve the deal that would create a diversified Australian-focused gold and antimony producer.

Champion Iron Limited has launched a US$450 million senior notes offering due 2032 to refinance existing debt and support corporate initiatives, signaling strategic financial repositioning.

RareX Limited confirms exceptional high-grade gallium mineralisation at its Cummins Range project, positioning it as a strategic critical minerals asset amid soaring global demand and supply risks.

Treasury Wine Estates projects strong fiscal 2025 earnings driven by luxury brands Penfolds and DAOU, while unveiling a new divisional model and a significant share buyback.

Eden Innovations is set to consolidate its shares and launch a $6.6 million entitlement offer to reduce debt and fund global expansion of its EdenCrete® and OptiBlend® products.

Staude Capital Global Value Fund Limited has completed a $16.9 million wholesale placement and opened a Share Purchase Plan for existing shareholders, aiming to deploy capital through its discount capture strategy.

xReality Group is rapidly transforming its business by focusing on its high-growth Operator XR training platform, while preparing to divest legacy entertainment assets. The company reports record revenue and expanding global reach, particularly in the US defence and law enforcement sectors.

Argenica Therapeutics has reported compelling preclinical results for ARG-007, demonstrating sustained neuroprotection and functional recovery in a ferret model of moderate traumatic brain injury. These findings pave the way for clinical trials targeting a major unmet medical need.